Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Huber

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
American Journal of Hospital Pharmacy|July 1, 1993
Strategic management of biotechnology agentsS L Huber
Pharmacotherapy|January 1, 1992
Strategic planning for the colony-stimulating factorsS L Huber
Seminars in Oncology|October 1, 1988
Reimbursement issues with interferon therapiesS L Huber
Cancer|November 1, 1993
Impact of clinical trial protocols on patient care systems at the University of Texas M.D. Anderson Cancer CenterS L Huber
Drug Intelligence & Clinical Pharmacy|October 1, 1981
Internal standards: rationale for use in a drug utilization review programS L Huber, R A Patry
Hospital Formulary|January 11, 1981
Physician and pharmacist perspectives on drug utilizationR A Patry, S L Huber, W Lee
The Oncologist|July 8, 2000
The consequences of diarrhea occurring during chemotherapy for colorectal cancer: a retrospective studyR B Arbuckle, S L Huber, C Zacker
The Annals of Pharmacotherapy|September 20, 1997
Comment: cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemiaS N Finkelstein, S L Huber, P E Greenberg
American Journal of Hospital Pharmacy|November 1, 1982
Influencing drug use through prescribing restrictionsS L Huber, R A Patry, H D Hudson
Hospital Formulary|July 9, 1984
Strengthening the formulary system by implementing a drug usage guidelines programS L Huber, R A Patry, H D Hudson, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
American Journal of Hospital Pharmacy|July 1, 1993
Strategic management of biotechnology agentsS L Huber
Pharmacotherapy|January 1, 1992
Strategic planning for the colony-stimulating factorsS L Huber
Seminars in Oncology|October 1, 1988
Reimbursement issues with interferon therapiesS L Huber
Cancer|November 1, 1993
Impact of clinical trial protocols on patient care systems at the University of Texas M.D. Anderson Cancer CenterS L Huber
Drug Intelligence & Clinical Pharmacy|October 1, 1981
Internal standards: rationale for use in a drug utilization review programS L Huber, R A Patry
Hospital Formulary|January 11, 1981
Physician and pharmacist perspectives on drug utilizationR A Patry, S L Huber, W Lee
The Oncologist|July 8, 2000
The consequences of diarrhea occurring during chemotherapy for colorectal cancer: a retrospective studyR B Arbuckle, S L Huber, C Zacker
The Annals of Pharmacotherapy|September 20, 1997
Comment: cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemiaS N Finkelstein, S L Huber, P E Greenberg
American Journal of Hospital Pharmacy|November 1, 1982
Influencing drug use through prescribing restrictionsS L Huber, R A Patry, H D Hudson
Hospital Formulary|July 9, 1984
Strengthening the formulary system by implementing a drug usage guidelines programS L Huber, R A Patry, H D Hudson, et al.
Pageof 2